Les Loges, France

Maxime Bessieres


Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maxime Bessieres: Innovator in Antiviral Treatments

Introduction

Maxime Bessieres is a notable inventor based in Les Loges, France. He has made significant contributions to the field of antiviral treatments, holding 2 patents that focus on innovative compounds for combating viral infections. His work is particularly relevant in the context of emerging viral diseases.

Latest Patents

Bessieres' latest patents include groundbreaking inventions aimed at treating viral infections. One of his patents is for "Antiviral acyclonucleoside analogues for use in treating a viral infection." This invention concerns a compound with a specific formula, which is utilized as a medicament for treating viral infections. Another significant patent is for "Benzimidazol derivatives for treating filovirus infection." This invention relates to compounds that include a benzimidazole scaffold, which are used for the treatment of viral diseases, particularly targeting filoviruses and retroviruses such as Ebola and HIV.

Career Highlights

Throughout his career, Maxime Bessieres has worked with esteemed institutions, including the Centre National de la Recherche Scientifique and the University of Orléans. His research has contributed to the advancement of antiviral therapies, showcasing his commitment to addressing critical health challenges.

Collaborations

Bessieres has collaborated with notable colleagues, including Luigi A. Agrofoglio and Vincent Roy. These partnerships have further enriched his research and development efforts in the field of antiviral treatments.

Conclusion

Maxime Bessieres stands out as an innovative inventor dedicated to developing effective antiviral therapies. His patents reflect a deep understanding of viral infections and a commitment to improving public health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…